Source Pravda.Ru

Johnson & Johnson added warning to the label

Johnson & Johnson has added a new warning to the label for rheumatoid arthritis drug Remicade about blood-related problems that were fatal in some cases, the Food and Drug Administration said in a statement posted on its Web site on Tuesday.

Johnson & Johnson, in a letter to doctors also posted on the FDA Web site, said "the causal relationship" between Remicade and the blood problems "remains unclear."

The company also added warning language about rare cases of neurological problems experienced by patients treated with Remicade, the letter said.

The company advised doctors to be cautious about prescribing Remicade to patients with a history of significant blood abnormalities.

Johnson & Johnson shares gained 18 cents to $57.23 in afternoon trading on the New York Stock Exchange, informs Reuters.

The Malvern, Pa.-based company, working with the federal drug regulatory agency, revised its label for the monoclonal antibody.

Patients receiving the drug suffered reductions in their red and white blood cell, granulocyte and platelet counts, leaving them more vulnerable to abnormal bleeding and infections. In some instances, patients died. In rare instances, patients suffered central nervous system disorders, including confusing immune system responses that swelled, then decayed, blood vessels.

Remicade was approved for use in the United States on Aug. 24, 1998. Worldwide, 509,000 patients have taken it. In late July, a European advisory committee approved expanding its use for treating people with psoriatic arthritis, writes Seattle Post.

Read earlier news stories by PRAVDA.Ru

&to=http:// english.pravda.ru/society/2002/10/29/38855.html' target=_blank> International Conference Against Drugs Opens in ...

&to=http:// english.pravda.ru/columnists/2002/08/01/33661.html' target=_blank> The Right Stuff (Drugs and Democracy)

Comments
Africa's heart bleeds, who is to blame?
Woman sucks her men dry in bed like female spider
China wages trade war against US, remains largest investor in US debt
Russia mourns victims of Ilyushin Il-20 shootdown
How Russia can respond to Israel following Ilyushin Il20 shootdown
How Russia can respond to Israel following Ilyushin Il20 shootdown
Russia mourns victims of Ilyushin Il-20 shootdown
NATO's 5,000 warplanes ready to bomb Russia, Chinese media say
Ukraine's Poroshenko signs decree to terminate Treaty of Friendship with Russia
Ukraine's Poroshenko signs decree to terminate Treaty of Friendship with Russia
Putin speaks about God and warns Ukraine
Putin speaks about God and warns Ukraine
How Russia can respond to Israel following Ilyushin Il20 shootdown
Russia obediently sells RD-180 rocket engines to USA if and when requested
Russia obediently sells RD-180 rocket engines to USA if and when requested
Russia mourns victims of Ilyushin Il-20 shootdown
53 million Russians may lose their jobs within a few years
How Russia can respond to Israel following Ilyushin Il20 shootdown
MiG-31 supersonic fighter jet crashes in Central Russia, pilots eject
MiG-31 supersonic fighter jet crashes in Central Russia, pilots eject
MiG-31 supersonic fighter jet crashes in Central Russia, pilots eject